Cancer patients must shield body from daylight while trialling new treatment
Irene Williams, 38, who lives in Llandudno in north Wales decided to take part in the international trial of new drug Amphinex, which could help with her inoperable bile duct cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - September 4, 2014 Category: Consumer Health News Source Type: news
'One lady ran away screaming': Cancer patients must shield EVERY inch of her body from daylight while trialling pioneering new treatment
Irene Williams, 38, who lives in Llandudno in north Wales decided to take part in the international trial of new drug Amphinex, which could help with her inoperable bile duct cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - September 4, 2014 Category: Consumer Health News Source Type: news
Gene mutation may lead to treatment for liver cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2014 Category: Global & Universal Source Type: news
TGen and Scottsdale Healthcare begin study of new drug for patients with solid tumors
(The Translational Genomics Research Institute) The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, especially those with brain tumors and gallbladder bile duct cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2014 Category: Cancer & Oncology Source Type: news
The Cholangiocarcinoma Foundation Launches “Show Us Your Card”...
A new Biliary Emergency Information Card has been created to ensure prompt treatment for patients with cholangiocarcinoma.(PRWeb June 01, 2014)Read the full story at http://www.prweb.com/releases/2014/05/prweb11899341.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 1, 2014 Category: Pharmaceuticals Source Type: news
Mount Sinai researchers to present studies at American Society of Clinical Oncology Meeting
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2014 American Society of Clinical Oncology meeting May 30-June 3, 2014, in Chicago, including data on new treatment approaches for thyroid, head and neck, and recurrent ovarian cancers; and new biomarkers for bile duct cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 31, 2014 Category: Cancer & Oncology Source Type: news
Could this be the latest cure for cancer? Mother-of-six is injected with her OWN disease-fighting cells grown in the lab
Scientists in Maryland harvested Melinda Bachini's cancer-fighting immune cells, replicating them before implanting them back into her body to help her battle a rare bile duct cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2014 Category: Consumer Health News Source Type: news
One Woman's Cancer Battle Highlights Promise of New Treatment
Melinda Bachini received experimental therapy that used her own immune cells to shrink her tumorsSource: HealthDay
Related MedlinePlus Page: Bile Duct Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 8, 2014 Category: Consumer Health News Source Type: news
The Cholangiocarcinoma Foundation and Patient Crossroads Partner to...
Patients, Researchers, Industry and Leading Medical Experts Join Forces to Accelerate Cholangiocarcinoma Research(PRWeb May 02, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11735117.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 3, 2014 Category: Pharmaceuticals Source Type: news
Model Predicts Survival in Intrahepatic Cholangiocarcinoma Model Predicts Survival in Intrahepatic Cholangiocarcinoma
An international multicenter study identified 6 prognostic variables that were incorporated into a nomogram to predict prognosis better than staging alone. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Researchers Use Genomic Sequencing to Help Identify New Therapies for Bile Duct Cancer
Study targets EGFR and FGFR cellular pathways to treat rare disease SCOTTSDALE, Ariz. — Feb. 13, 2014 — Physicians at Mayo Clinic’s Center for Individualized Medicine and researchers at the Translational Genomics Research Institute (TGen) have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies. Potential new treatment approaches are being validated to develop new tests [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - February 11, 2014 Category: Hospital Management Source Type: news
Molecular secrets of bile duct cancers
A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, Fundeni Clinical Institute (Romania) and Koen Kaen University (Thailand), have made a seminal breakthrough in understanding the molecular basis of bile duct cancer or cholangiocarcinoma, a rare but highly lethal form of liver cancer. The team, led by Professors Teh Bin Tean, Patrick Tan, Steve Rozen, Irinel Popescu and Vajaraphongsa Bhudhisawasdi, used advanced DNA sequencing technologies to map the complete repertoire of human genes disrupted in cholangiocarcinoma... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 6, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Singapore scientists expose molecular secrets of bile duct cancers from different countries
(SingHealth) A Singapore-led scientific team discovers critical genes in bile duct cancers from different parts of the world.New molecular insights point to potentially different treatment regimens for the same cancer type depending on underlying genetic alterations. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 3, 2013 Category: Global & Universal Source Type: news
Cancer Care
mas123Mon, 09/30/2013 - 11:09
Treatment TermsCancer
Document TitleDurham, Raleigh, Cary, NC
Carousel
Header Imagetreatment_infusion_1500x4302.jpg
Image TextComprehensive cancer care and support, close to where you live and work
Button LinkFind a Doctor
Type of Landing pageAdult
Sub-TitleCancer Centers in Durham, Raleigh, Cary, and Throughout North Carolina
Corresponding adult/pediatric pageView Childhood Cancer Care
OverviewYou don ’t have to travel far to receive the latest advances in cancer care. Duke cancer centers in Durham, Raleigh, and Cary offer you access to cancer doctors, treatmen...
Source: dukehealth.org: Duke Health News - September 30, 2013 Category: Consumer Health News Authors: mas123 Source Type: news
Japanese workers with cancer named disaster victims
TOKYO, June 14 (UPI) -- The Japanese government has recognized three longtime printing industry workers who contracted bile duct cancer on the job as workplace disaster victims. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 14, 2013 Category: Consumer Health News Source Type: news
